FDA Approves First Immunotherapy-Companion Diagnostic Combo for Lung Cancer
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Earlier this week, new ground was broken in the field of cancer immunotherapy when the U.S. Food and Drug...
Among the many types of cancer acknowledged during the month of September is lymphoma, a cancer arising from a...
Government task force drafts recommendations for low-dose aspirin for the prevention of cardiovascular disease and colorectal cancer; a study...
The inaugural International Cancer Immunotherapy Conference, hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy...
Two studies published today in the AACR's journal Cancer Research describe developing CAR T cells to make them safe...
Guest Post by Kelvin Lee, MD Roswell Park Cancer Institute
Eric R. Lutz, PhD, a recipient of the Pancreatic Cancer Action Network-AACR Career Development Award, studies the development of...
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...